Highlights of Current Issue 2026 | Vol 04 | Issue 04
Triple-negative breast cancer (TNBC) remains a formidable clinical challenge, characterized by its aggressive phenotype, immune evasion, and lack of targeted therapies. T...
The present study focuses on the development and evaluation of a novel nutraceutical formulation containing calcium, magnesium, zinc, vitamin D3, and vitamin B12 using al...
Pyrazinamide (PZA) is still a cornerstone of short-course tuberculosis (TB) treatment due to its sterilizing effect against persistent Mycobacterium tuberculosis populati...
Epistaxis is a frequently encountered clinical condition with multifactorial etiology, including local nasal pathology, systemic diseases, and pharmacological agents. Cal...
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer characterized by the absence of estrogen, progesterone, and human epiderm...
The hydrophobic nature of the majority of medicines makes successful in vivo delivery difficult. The effectiveness of such drugs has been greatly improved by the reductio...
Effective pain management requires a therapeutic approach capable of delivering rapid onset of action along with prolonged drug release. Conventional dosage forms are gen...
Fixed-dose combination (FDC) tablets, which bundle two or more active ingredients into one pill, have turned into a real gamechanger for modern medicine. They do way more...
Ficus racemosa Linn. (Cluster fig), a member of the Moraceae family, is widely recognized in traditional medicinal systems for its broad therapeutic applications. Various...
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from impaired insulin secretion, insulin resistance, or both. The gl...
The growing demand for sustainable and organic cosmetics has driven interest in formulating lipsticks using natural ingredients. This study focuses on the formulation and...
Poor aqueous solubility remains a primary barrier to oral bioavailability for many new chemical entities. Strategies that convert poorly soluble actives into higher-energ...